+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Small Molecule Chemical Drug CDMO Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Small Molecule Chemical Drug CDMO Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
New

Small Molecule Chemical Drug CDMO Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6078457
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The contract development and manufacturing organization (CDMO) market for small molecule chemical drugs stands at a critical juncture, shaped by rapid technological advancements, shifting supply chain dynamics, and escalating demand for specialized pharmaceutical services. As companies seek to accelerate time to market, optimize production costs, and maintain rigorous quality standards, the role of CDMOs has evolved from commoditized service providers to strategic innovation partners. Continuous flow chemistry, biocatalysis, and advanced analytical testing have redefined best practices, driving efficiency across the drug development lifecycle. Moreover, emerging regulatory frameworks and evolving patient needs are reshaping how organizations approach capacity planning and research collaborations.

Against this backdrop, decision-makers must navigate an increasingly complex environment in which agility, scalability, and regulatory compliance become decisive competitive advantages. In addition, heightened focus on sustainability and green chemistry compels industry participants to rethink traditional process designs and material sourcing. This introduction establishes the landscape for a comprehensive examination of key trends, tariff impacts, segmentation opportunities, regional dynamics, and competitive benchmarks that will inform actionable strategies. By framing these critical dimensions up front, readers can appreciate how small molecule CDMOs are driving innovation, mitigating risks, and unlocking new growth avenues within the pharmaceutical value chain.

Transformative Shifts Driving Industry Evolution

The CDMO sector is undergoing transformative shifts driven by technological breakthroughs, evolving customer expectations, and heightened regulatory scrutiny. First, continuous processing has progressed from pilot-scale experiments to fully integrated manufacturing platforms, delivering superior reaction control, reduced waste, and accelerated cycle times. In parallel, biocatalysis applications have expanded beyond niche compounds to mainstream process options, enabling milder reaction conditions and higher stereoselectivity. Additionally, digitalization initiatives-from real-time analytics to AI-driven process optimization-have begun to permeate quality systems, empowering teams with predictive control over critical process parameters.

Moreover, strategic alliances between pharmaceutical sponsors and CDMOs have matured into co-development partnerships, fostering shared risk models and joint innovation roadmaps. Regulatory harmonization efforts across major markets are further streamlining approval pathways, although they require rigorous compliance frameworks and robust documentation practices. Sustainability has emerged as a core differentiator, with leading CDMOs committing to carbon-neutral operations and solvent recovery programs. As a result of these combined forces, service offerings are shifting from one-off manufacturing runs to end-to-end platforms encompassing discovery support, scale-up, and commercial supply. These transformative currents are redefining the value proposition of small molecule CDMOs and setting new benchmarks for operational excellence.

Navigating the 2025 United States Tariff Landscape

The United States 2025 tariff adjustments on imported chemical intermediates have recalibrated cost structures across the small molecule CDMO landscape. Tariffs imposed on select precursor categories prompted manufacturers to revisit sourcing strategies and to explore alternative suppliers within non-tariffed regions. Consequently, some organizations have accelerated investments in domestic production capacity to mitigate exposure to fluctuating duty rates, while others have implemented cost-pass-through models to preserve margin integrity. In addition, tariff uncertainty has elevated the importance of agile supply chain orchestration tools, enabling real-time scenario planning and dynamic procurement decisions.

As a result, CDMOs have intensified efforts to localize key steps in the manufacturing value chain, from raw material synthesis to formulation, to reduce dependency on high-tariff import lanes. Meanwhile, sustained dialogue between industry associations and regulatory bodies seeks to clarify classification definitions and to secure tariff relief for strategic compounds. These combined initiatives drive both short-term cost containment and long-term resiliency, ensuring that project timelines remain on track and that quality standards do not erode. Ultimately, the 2025 tariffs serve as a catalyst for supply chain transformation, compelling stakeholders to balance near-term financial impacts with enduring operational agility.

Key Segmentation Insights for Strategic Planning

A nuanced understanding of market segmentation reveals distinct pockets of opportunity and specialization. In terms of product type, the industry divides into large small molecules-further differentiated by modified and radioactive derivatives-and standard small molecules, each demanding tailored analytical and manufacturing protocols. When considering manufacturing processes, biocatalysis, chemical synthesis, and custom contract services coexist alongside advanced flow chemistry approaches, which themselves split into batch processing and continuous processing streams. Therapeutic areas span cardiovascular, dermatology-including systemic and topical treatments-infectious diseases, neurology with neurodegenerative and psychiatric disorder focuses, and oncology, each driving unique scale-up and regulatory requirements.

End-user segments comprise academic and research institutions-both universities and dedicated research organizations-alongside biotech firms and established pharmaceutical companies, each applying CDMO offerings to distinct development pipelines. Service categories range from analytical and laboratory services through pre-clinical evaluation, clinical-stage development, and commercial manufacturing. Chemical types span inorganic compounds, organic compounds, and fully synthesized drug entities, demanding variable reactor designs and material handling systems. Finally, application domains cover in-vitro and in-vivo diagnostics as well as human and veterinary medicines, prompting tailored quality control standards. By mapping revenue streams and resource investments across these dimensions, industry participants can prioritize high-value segments and align capabilities with evolving market demands.

Regional Developments Shaping Market Opportunities

Regional heterogeneity shapes the competitive landscape and informs localization strategies. In the Americas, robust infrastructure and a favorable regulatory environment support large-scale commercial manufacturing, with the United States leading capacity expansion and Brazil emerging as a cost-effective hub for early-stage development. Across Europe, the Middle East & Africa, stringent quality standards converge with government incentives to attract green chemistry initiatives, while established hubs in Ireland, Germany, and Switzerland drive innovation in both bespoke services and volume supply. The Asia-Pacific region marries scale and cost efficiency, with China and India dominating contract volumes, Japan focusing on high-precision small batch opportunities, and South Korea investing in advanced continuous manufacturing platforms.

Each region’s regulatory landscape, tax regime, and talent pool contribute to differentiated risk-reward profiles. As a result, leading CDMOs employ a multi-regional footprint to balance capacity, mitigate geopolitical exposure, and optimize transit times. By synthesizing these regional insights, organizations can craft network designs that align with therapeutic priorities, regulatory timelines, and cost targets, all while maintaining the flexibility to respond to emerging global events.

Benchmarking Leading Contract Development and Manufacturing Organizations

Benchmarking key market participants reveals strategic differentiators and service breadth. Aenova Group brings deep expertise in oral solid dose formulation, while Almac Group offers tightly integrated discovery to commercial workflows. AMRI emphasizes research-driven process innovation, and Cambrex Corporation specializes in fine chemical intermediates and customized small molecule APIs. Catalent, Inc. leverages global end-to-end capabilities spanning drug formulation to packaging, whereas Corden Pharma aligns its cGMP facilities to serve niche therapeutic segments. Flexion Therapeutics, Inc. excels in targeted small molecule development, and Hovione LLC is renowned for scalable inhalation APIs.

Lonza Group AG commands significant capacity in both microbial and chemical manufacturing, supported by Patheon by Thermo Fisher Scientific’s expansive network. Piramal Pharma Solutions provides modular assets optimized for rapid tech transfers, and Porton Pharma Solutions Ltd. delivers focused support for complex molecules. Recipharm AB’s technical services platform enhances early-stage analytical rigor, while Siegfried AG’s vertically integrated operations ensure seamless scale transitions. WuXi AppTec Co., Ltd. completes the picture with an end-to-end model that integrates discovery, development, and manufacturing under a single quality umbrella. By evaluating these profiles, decision-makers can identify best-in-class practices and partnership models aligned with their strategic objectives.

Actionable Recommendations for Industry Leadership

To capture growth and maintain competitive advantage, industry leaders should pursue several high-impact initiatives. First, they must prioritize continuous manufacturing investments, harnessing digital twins and process analytical technology to ensure robust scale-up and consistent product quality. Second, diversifying supplier portfolios and near-shoring critical precursor production will reduce exposure to tariff volatility and geopolitical disruptions. Third, embedding green chemistry metrics into project roadmaps can both meet regulatory expectations and reinforce corporate sustainability commitments. Fourth, fostering deeper co-development relationships with sponsors will align innovation incentives and accelerate candidate selection. Fifth, building advanced regulatory intelligence capabilities will streamline global submissions and expedite market access. Finally, integrating modular, flexible facility designs will allow rapid capacity reallocation in response to pipeline shifts, ensuring that resources match the evolving needs of therapeutic portfolios.

Conclusion: Positioning for Sustainable Growth

As the small molecule CDMO market continues to evolve, organizations that move decisively on technology adoption, supply chain resilience, and strategic partnerships will secure lasting differentiation. By leveraging detailed segmentation insights, regional market dynamics, and competitive benchmarks, stakeholders can align their service portfolios with the highest-value opportunities. Embracing sustainability goals and regulatory foresight will not only mitigate risk but also enhance brand reputation among sponsors. Ultimately, the companies that integrate these critical levers will capture new growth avenues and position themselves as preferred partners in a rapidly shifting pharmaceutical ecosystem.

Market Segmentation & Coverage

This research report categorizes the Small Molecule Chemical Drug CDMO Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Large Small Molecules
    • Modified Small Molecules
    • Radioactive Small Molecules
  • Small Molecules
  • Biocatalysis
  • Chemical Synthesis
  • Custom Manufacturing
  • Flow Chemistry
    • Batch Processing
    • Continuous Processing
  • Cardiovascular
  • Dermatology
    • Systemic Treatments
    • Topical Treatments
  • Infectious Diseases
  • Neurology
    • Neurodegenerative Disorders
    • Psychiatric Disorders
  • Oncology
  • Academic and Research Institutions
    • Research Organizations
    • Universities
  • Biotech Companies
  • Pharmaceutical Companies
  • Analytical and Laboratory Services
  • Clinical-Stage Development
  • Commercial Manufacturing
  • Pre-Clinical Development
  • Inorganic Compounds
  • Organic Compounds
  • Synthesized Drugs
  • Diagnostics
    • In-Vitro Diagnostics
    • In-Vivo Diagnostics
  • Human Medicine
  • Veterinary Medicine

This research report categorizes the Small Molecule Chemical Drug CDMO Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Small Molecule Chemical Drug CDMO Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Aenova Group
  • Almac Group
  • AMRI (Albany Molecular Research Inc.)
  • Cambrex Corporation
  • Catalent, Inc.
  • Corden Pharma
  • Flexion Therapeutics, Inc.
  • Hovione LLC
  • Lonza Group AG
  • Patheon by Thermo Fisher Scientific
  • Piramal Pharma Solutions
  • Porton Pharma Solutions Ltd.
  • Recipharm AB
  • Siegfried AG
  • WuXi AppTec Co., Ltd.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Small Molecule Chemical Drug CDMO Market, by Product Type
8.1. Introduction
8.2. Large Small Molecules
8.2.1. Modified Small Molecules
8.2.2. Radioactive Small Molecules
8.3. Small Molecules
9. Small Molecule Chemical Drug CDMO Market, by Manufacturing Process
9.1. Introduction
9.2. Biocatalysis
9.3. Chemical Synthesis
9.4. Custom Manufacturing
9.5. Flow Chemistry
9.5.1. Batch Processing
9.5.2. Continuous Processing
10. Small Molecule Chemical Drug CDMO Market, by Therapeutic Area
10.1. Introduction
10.2. Cardiovascular
10.3. Dermatology
10.3.1. Systemic Treatments
10.3.2. Topical Treatments
10.4. Infectious Diseases
10.5. Neurology
10.5.1. Neurodegenerative Disorders
10.5.2. Psychiatric Disorders
10.6. Oncology
11. Small Molecule Chemical Drug CDMO Market, by End-User
11.1. Introduction
11.2. Academic and Research Institutions
11.2.1. Research Organizations
11.2.2. Universities
11.3. Biotech Companies
11.4. Pharmaceutical Companies
12. Small Molecule Chemical Drug CDMO Market, by Service
12.1. Introduction
12.2. Analytical and Laboratory Services
12.3. Clinical-Stage Development
12.4. Commercial Manufacturing
12.5. Pre-Clinical Development
13. Small Molecule Chemical Drug CDMO Market, by Chemical Type
13.1. Introduction
13.2. Inorganic Compounds
13.3. Organic Compounds
13.4. Synthesized Drugs
14. Small Molecule Chemical Drug CDMO Market, by Application
14.1. Introduction
14.2. Diagnostics
14.2.1. In-Vitro Diagnostics
14.2.2. In-Vivo Diagnostics
14.3. Human Medicine
14.4. Veterinary Medicine
15. Americas Small Molecule Chemical Drug CDMO Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Small Molecule Chemical Drug CDMO Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Small Molecule Chemical Drug CDMO Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Aenova Group
18.3.2. Almac Group
18.3.3. AMRI (Albany Molecular Research Inc.)
18.3.4. Cambrex Corporation
18.3.5. Catalent, Inc.
18.3.6. Corden Pharma
18.3.7. Flexion Therapeutics, Inc.
18.3.8. Hovione LLC
18.3.9. Lonza Group AG
18.3.10. Patheon by Thermo Fisher Scientific
18.3.11. Piramal Pharma Solutions
18.3.12. Porton Pharma Solutions Ltd.
18.3.13. Recipharm AB
18.3.14. Siegfried AG
18.3.15. WuXi AppTec Co., Ltd.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. SMALL MOLECULE CHEMICAL DRUG CDMO MARKET MULTI-CURRENCY
FIGURE 2. SMALL MOLECULE CHEMICAL DRUG CDMO MARKET MULTI-LANGUAGE
FIGURE 3. SMALL MOLECULE CHEMICAL DRUG CDMO MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY MANUFACTURING PROCESS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY MANUFACTURING PROCESS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY SERVICE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY SERVICE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY CHEMICAL TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY CHEMICAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 20. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. SMALL MOLECULE CHEMICAL DRUG CDMO MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY LARGE SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY MODIFIED SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY RADIOACTIVE SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY LARGE SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY BIOCATALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY CUSTOM MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY FLOW CHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY BATCH PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY CONTINUOUS PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY FLOW CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY SYSTEMIC TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY TOPICAL TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY PSYCHIATRIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY ANALYTICAL AND LABORATORY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY CLINICAL-STAGE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY COMMERCIAL MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY PRE-CLINICAL DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY CHEMICAL TYPE, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY INORGANIC COMPOUNDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY ORGANIC COMPOUNDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY SYNTHESIZED DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY IN-VITRO DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY IN-VIVO DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY HUMAN MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY VETERINARY MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY LARGE SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY FLOW CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY CHEMICAL TYPE, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY LARGE SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY FLOW CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY CHEMICAL TYPE, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY LARGE SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY FLOW CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY CHEMICAL TYPE, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 95. CANADA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. CANADA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY LARGE SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 97. CANADA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 98. CANADA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY FLOW CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 99. CANADA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 100. CANADA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 101. CANADA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 102. CANADA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. CANADA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 104. CANADA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 105. CANADA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY CHEMICAL TYPE, 2018-2030 (USD MILLION)
TABLE 106. CANADA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. CANADA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 108. MEXICO SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. MEXICO SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY LARGE SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 110. MEXICO SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 111. MEXICO SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY FLOW CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 112. MEXICO SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 113. MEXICO SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 114. MEXICO SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 115. MEXICO SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. MEXICO SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 117. MEXICO SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 118. MEXICO SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY CHEMICAL TYPE, 2018-2030 (USD MILLION)
TABLE 119. MEXICO SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. MEXICO SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY LARGE SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY FLOW CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY CHEMICAL TYPE, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. ASIA-PACIFIC SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY LARGE SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 138. ASIA-PACIFIC SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY FLOW CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 144. ASIA-PACIFIC SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY CHEMICAL TYPE, 2018-2030 (USD MILLION)
TABLE 146. ASIA-PACIFIC SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. ASIA-PACIFIC SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 148. ASIA-PACIFIC SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 149. AUSTRALIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. AUSTRALIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY LARGE SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 151. AUSTRALIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 152. AUSTRALIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY FLOW CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 153. AUSTRALIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 154. AUSTRALIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 155. AUSTRALIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 156. AUSTRALIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. AUSTRALIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 158. AUSTRALIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 159. AUSTRALIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY CHEMICAL TYPE, 2018-2030 (USD MILLION)
TABLE 160. AUSTRALIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. AUSTRALIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 162. CHINA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 163. CHINA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY LARGE SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 164. CHINA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 165. CHINA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY FLOW CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 166. CHINA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 167. CHINA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 168. CHINA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 169. CHINA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. CHINA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 171. CHINA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 172. CHINA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY CHEMICAL TYPE, 2018-2030 (USD MILLION)
TABLE 173. CHINA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. CHINA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 175. INDIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 176. INDIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY LARGE SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 177. INDIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 178. INDIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY FLOW CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 179. INDIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 180. INDIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 181. INDIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 182. INDIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. INDIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 184. INDIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 185. INDIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY CHEMICAL TYPE, 2018-2030 (USD MILLION)
TABLE 186. INDIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. INDIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 188. INDONESIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. INDONESIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY LARGE SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 190. INDONESIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 191. INDONESIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY FLOW CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 192. INDONESIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 193. INDONESIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 194. INDONESIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 195. INDONESIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 196. INDONESIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 197. INDONESIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 198. INDONESIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY CHEMICAL TYPE, 2018-2030 (USD MILLION)
TABLE 199. INDONESIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. INDONESIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 201. JAPAN SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 202. JAPAN SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY LARGE SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 203. JAPAN SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 204. JAPAN SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY FLOW CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 205. JAPAN SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 206. JAPAN SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 207. JAPAN SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 208. JAPAN SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 209. JAPAN SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 210. JAPAN SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 211. JAPAN SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY CHEMICAL TYPE, 2018-2030 (USD MILLION)
TABLE 212. JAPAN SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. JAPAN SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 214. MALAYSIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 215. MALAYSIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY LARGE SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 216. MALAYSIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY FLOW CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 219. MALAYSIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 220. MALAYSIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 221. MALAYSIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 222. MALAYSIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 223. MALAYSIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 224. MALAYSIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY CHEMICAL TYPE, 2018-2030 (USD MILLION)
TABLE 225. MALAYSIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. MALAYSIA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 227. PHILIPPINES SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 228. PHILIPPINES SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY LARGE SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 229. PHILIPPINES SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 230. PHILIPPINES SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY FLOW CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 231. PHILIPPINES SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 232. PHILIPPINES SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 233. PHILIPPINES SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 234. PHILIPPINES SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. PHILIPPINES SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 236. PHILIPPINES SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 237. PHILIPPINES SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY CHEMICAL TYPE, 2018-2030 (USD MILLION)
TABLE 238. PHILIPPINES SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. PHILIPPINES SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 240. SINGAPORE SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 241. SINGAPORE SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY LARGE SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 242. SINGAPORE SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 243. SINGAPORE SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY FLOW CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 244. SINGAPORE SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 245. SINGAPORE SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 246. SINGAPORE SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 247. SINGAPORE SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 248. SINGAPORE SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 249. SINGAPORE SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 250. SINGAPORE SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY CHEMICAL TYPE, 2018-2030 (USD MILLION)
TABLE 251. SINGAPORE SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. SINGAPORE SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 253. SOUTH KOREA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. SOUTH KOREA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY LARGE SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 255. SOUTH KOREA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 256. SOUTH KOREA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY FLOW CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 257. SOUTH KOREA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 258. SOUTH KOREA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 259. SOUTH KOREA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 260. SOUTH KOREA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 261. SOUTH KOREA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 262. SOUTH KOREA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 263. SOUTH KOREA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY CHEMICAL TYPE, 2018-2030 (USD MILLION)
TABLE 264. SOUTH KOREA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. SOUTH KOREA SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 266. TAIWAN SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. TAIWAN SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY LARGE SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 268. TAIWAN SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 269. TAIWAN SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY FLOW CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 270. TAIWAN SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 271. TAIWAN SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 272. TAIWAN SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 273. TAIWAN SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 274. TAIWAN SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 275. TAIWAN SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY CHEMICAL TYPE, 2018-2030 (USD MILLION)
TABLE 277. TAIWAN SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. TAIWAN SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 279. THAILAND SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 280. THAILAND SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY LARGE SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 281. THAILAND SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 282. THAILAND SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY FLOW CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 283. THAILAND SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 284. THAILAND SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 285. THAILAND SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 286. THAILAND SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 287. THAILAND SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 288. THAILAND SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 289. THAILAND SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY CHEMICAL TYPE, 2018-2030 (USD MILLION)
TABLE 290. THAILAND SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 291. THAILAND SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 292. VIETNAM SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 293. VIETNAM SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY LARGE SMALL MOLECULES, 2018-2030 (USD MILLION)
TABLE 294. VIETNAM SMALL MOLECULE CHEMICAL DRUG CDMO MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 295. VIETNAM SMALL MOLECULE CHEMICAL D

Companies Mentioned

  • Aenova Group
  • Almac Group
  • AMRI (Albany Molecular Research Inc.)
  • Cambrex Corporation
  • Catalent, Inc.
  • Corden Pharma
  • Flexion Therapeutics, Inc.
  • Hovione LLC
  • Lonza Group AG
  • Patheon by Thermo Fisher Scientific
  • Piramal Pharma Solutions
  • Porton Pharma Solutions Ltd.
  • Recipharm AB
  • Siegfried AG
  • WuXi AppTec Co., Ltd.

Methodology

Loading
LOADING...

Related Topics

Related Reports

U.S. Small Molecule Innovator API CDMO Market Size, Share & Trends Analysis Report by Stage Type (Preclinical, Clinical, Commercial), Customer Type, Therapeutic Area, Region, and Segment Forecasts, 2024-2030 - Product Image

U.S. Small Molecule Innovator API CDMO Market Size, Share & Trends Analysis Report by Stage Type (Preclinical, Clinical, Commercial), Customer Type, Therapeutic Area, Region, and Segment Forecasts, 2024-2030

  • Report
  • 150 Pages
  • United States
From
North America Biotechnology And Pharmaceutical Services Outsourcing Market Size, Share & Trends Analysis Report By Service (Consulting, Regulatory Affairs), By End Use, By Country, And Segment Forecasts, 2024 - 2030 - Product Image

North America Biotechnology And Pharmaceutical Services Outsourcing Market Size, Share & Trends Analysis Report By Service (Consulting, Regulatory Affairs), By End Use, By Country, And Segment Forecasts, 2024 - 2030

  • Report
  • 110 Pages
  • North America
From
Small Molecule Innovator CDMO - Global Strategic Business Report - Product Image

Small Molecule Innovator CDMO - Global Strategic Business Report

  • Report
  • 66 Pages
  • Global
From
Small Molecule Innovator CDMO Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Image

Small Molecule Innovator CDMO Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Investigational New Drug CDMO - Global Strategic Business Report - Product Image

Investigational New Drug CDMO - Global Strategic Business Report

  • Report
  • 162 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.